Cullinan Oncology, Inc.·4

Dec 22, 5:30 PM ET

SUMER JACQUELYN L 4

4 · Cullinan Oncology, Inc. · Filed Dec 22, 2023

Insider Transaction Report

Form 4
Period: 2023-12-21
SUMER JACQUELYN L
Chief Legal Officer
Transactions
  • Sale

    Common Stock

    2023-12-21$8.50/sh1,400$11,90044,133 total
Footnotes (2)
  • [F1]Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.
  • [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.49 to $8.50. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4